Hydroxyzinum Teva

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzinum Teva, is a first‑generation H1 antihistamine presented as a sterile solution for intraarticular, intravenous, and periarticular use. It treats allergic skin reactions, anxiety, and provides sedation before or after surgical procedures. GNH USA supplies Hydroxyzinum Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Hydroxyzinum Teva is a first‑generation H1 antihistamine used to manage conditions mediated by histamine release and related anxiety. - Allergic skin reactions (pruritus): reduces itching and skin inflammation. - Anxiety and tension: alleviates nervousness and promotes calmness. - Pre‑ or post‑operative sedation: provides short‑term sedation for surgical patients. - Nausea and vomiting adjunct: helps control postoperative nausea when used with other anti‑emetics.

Hydroxyzinum Teva may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to throat discomfort. - Blurred vision: temporary visual disturbances. - Constipation: slowed gastrointestinal motility. - Headache: mild to moderate cranial pain. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening. - Seizures: convulsive episodes in susceptible individuals. - Anaphylaxis: acute allergic reaction with airway compromise. - QT interval prolongation: risk of torsades de pointes. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy with Hydroxyzinum Teva, consider the following safety measures. - Assess patient history: verify no known hypersensitivity to hydroxyzine or related antihistamines. - Monitor sedation: advise patients to avoid operating machinery or driving until response is known. - Avoid concomitant CNS depressants: limit use with alcohol, opioids, or benzodiazepines to reduce additive sedation. - Caution in elderly: start with lower doses due to increased anticholinergic sensitivity. - Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. - Store at room temperature: keep in original container, protect from moisture and light.

Hydroxyzinum Teva can interact with several drug classes, altering its safety or efficacy profile.

Major Interactions (Avoid): - Central nervous system depressants (e.g., opioids, benzodiazepines): additive sedation and respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and syncope. - Strong anticholinergic agents (e.g., atropine, tricyclic antidepressants): heightened anticholinergic burden.

Moderate Interactions (Monitor Closely):\n- Alcohol: enhances drowsiness and impairment. - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): increase hydroxyzine plasma concentrations. - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce therapeutic effect.